Key result
IVUS and FFR guidance show comparable 2-year target vessel failure for intermediate coronary stenosis.
Why the study?
FFR- and IVUS-guided strategies show comparable outcomes in intermediate coronary lesions, but identifying low-risk deferred vessels and high-risk revascularized vessels could optimize treatment strategies.
Does an IVUS-guided strategy improve target vessel failure compared to an FFR-guided strategy in patients with intermediate coronary stenosis?
RCT (n=1,619)
Open-label
randomized
Yes
Does an IVUS-guided strategy improve target vessel failure compared to an FFR-guided strategy in patients with intermediate coronary stenosis?
IVUS- and FFR-guided strategies yield comparable 2-year outcomes for intermediate coronary stenosis, and specific parameters can identify low-risk deferred and high-risk revascularized vessels.
Supports equivalent 2-year safety for IVUS- or FFR-guided decisions in intermediate stenosis; extends observational data but leaves randomized confirmation open.
Importance: Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies. Objectives: To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment. Design, Setting, and Participants: This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] ≤3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] ≥70%) or an FFR-guided strategy (which recommended PCI for FFR ≤0.80). Data were analyzed from November to December 2022. Exposures: FFR or IVUS parameters within the deferred and revascularized vessels. Main Outcomes and Measures: The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years. Results: A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001). Conclusions and Relevance: In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) conducted an RCT in intermediate coronary stenosis (n=1,619). IVUS-guided strategy vs. FFR-guided strategy was evaluated on target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years. IVUS- and FFR-guided strategies for intermediate coronary stenosis showed comparable 2-year target vessel failure in deferred (3.8% vs 4.1%; P=.72) and revascularized (3.6% vs 3.7%; P=.95) vessels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: